Publication Author: Urban_Nicole

• Compliance of average- and intermediate-risk women to semiannual ovarian cancer screening.

  Drescher CW, Nelson J, Peacock S, Andersen MR, McIntosh MW, Urban N. Compliance of average- and intermediate-risk women to semiannual ovarian cancer screening. Cancer Epidemiol Biomarkers Prev. 2004 Apr;13(4):600-6.

  rakerr2

  April 1, 2004

• Ovarian cancer screening.

  Urban N, McIntosh MW, Andersen M, Karlan BY. Ovarian cancer screening. Hematol Oncol Clin North Am. 2003 Aug;17(4):989-1005, ix. Review.

  rakerr2

  August 1, 2003

• The HE4 (WFDC2) protein is a biomarker for ovarian carcinoma.

  Hellström I, Raycraft J, Hayden-Ledbetter M, Ledbetter JA, Schummer M, McIntosh M, Drescher C, Urban N, Hellström KE. The HE4 (WFDC2) protein is a biomarker for ovarian carcinoma. Cancer Res. 2003 Jul 1;63(13):3695-700.

  rakerr2

  July 1, 2003

• The case for early detection.

  Etzioni R, Urban N, Ramsey S, McIntosh M, Schwartz S, Reid B, Radich J, Anderson G, Hartwell L. The case for early detection. Nat Rev Cancer. 2003 Apr;3(4):243-52. Review.

  rakerr2

  April 1, 2003

• Breast cancer worry and mammography use by women with and without a family history in a population-based sample.

  Andersen MR, Smith R, Meischke H, Bowen D, Urban N. Breast cancer worry and mammography use by women with and without a family history in a population-based sample. Cancer Epidemiol Biomarkers Prev. 2003 Apr;12(4):314-20.

  rakerr2

  April 1, 2003

• Serologic analysis of ovarian tumor antigens reveals a bias toward antigens encoded on 17q.

  Stone B, Schummer M, Paley PJ, Thompson L, Stewart J, Ford M, Crawford M, Urban N, O’Briant K, Nelson BH. Serologic analysis of ovarian tumor antigens reveals a bias toward antigens encoded on 17q. Int J Cancer. 2003 Mar 10;104(1):73-84.

  rakerr2

  March 10, 2003

• A parametric empirical Bayes method for cancer screening using longitudinal observations of a biomarker.

  McIntosh MW, Urban N. A parametric empirical Bayes method for cancer screening using longitudinal observations of a biomarker. Biostatistics. 2003 Jan;4(1):27-40.

  rakerr2

  January 1, 2003

• Analysis of the cost-effectiveness of mammography promotion by volunteers in rural communities.

  Andersen MR, Hager M, Su C, Urban N. Analysis of the cost-effectiveness of mammography promotion by volunteers in rural communities. Health Educ Behav. 2002 Dec;29(6):755-70.

  rakerr2

  December 1, 2002

• Use of the American College of Radiology BI-RADS guidelines by community radiologists: concordance of assessments and recommendations assigned to screening mammograms.

  Lehman C, Holt S, Peacock S, White E, Urban N. Use of the American College of Radiology BI-RADS guidelines by community radiologists: concordance of assessments and recommendations assigned to screening mammograms. AJR Am J Roentgenol. 2002 Jul;179(1):15-

  rakerr2

  July 1, 2002

• Costs and cost-effectiveness of a clinical intervention to increase mammography utilization in an inner city public health hospital.

  Thompson B, Thompson LA, Andersen MR, Hager S, Taylor V, Urban N. Costs and cost-effectiveness of a clinical intervention to increase mammography utilization in an inner city public health hospital. Prev Med. 2002 Jul;35(1):87-96.

  rakerr2

  July 1, 2002